Literature DB >> 17687160

Tumor lysis syndrome after treatment of a gastrointestinal stromal tumor with the oral tyrosine kinase inhibitor sunitinib.

Philip J Saylor1, Tony R Reid.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17687160     DOI： 10.1200/JCO.2007.12.0790

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

Review 1.  A focused review of the pathogenesis, diagnosis, and management of tumor lysis syndrome for the interventional radiologist.

Authors:  Marcia Friedman; Pritesh R Patel; Damiano Rondelli
Journal:  Semin Intervent Radiol       Date:  2015-06       Impact factor: 1.513

2.  Sunitinib inducing tumor lysis syndrome in a patient treated for renal carcinoma.

Authors:  Judith Michels; Nathalie Lassau; Marine Gross-Goupil; Christophe Massard; Arnaud Mejean; Bernard Escudier
Journal:  Invest New Drugs       Date:  2009-06-24       Impact factor: 3.850

3.  An unusual presentation of tumor lysis syndrome in a patient with advanced gastric adenocarcinoma: case report and literature review.

Authors:  Danica Maria Vodopivec; Jose Enrique Rubio; Alessia Fornoni; Oliver Lenz
Journal:  Case Rep Med       Date:  2012-05-27

Review 4.  Tumor Lysis Syndrome in Solid Tumors: An up to Date Review of the Literature.

Authors:  Aibek E Mirrakhimov; Alaa M Ali; Maliha Khan; Aram Barbaryan
Journal:  Rare Tumors       Date:  2014-06-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.